Deltec Asset Management LLC Vyne Therapeutics Inc. Transaction History

Deltec Asset Management LLC

  • $478 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 13, 2021
SELL
$1.39 - $3.47 $495,522 - $1.24 Million
-356,491 Reduced 92.24%
30,000 $42,000
Q2 2021

Jul 15, 2021
SELL
$3.24 - $6.92 $178,200 - $380,600
-55,000 Reduced 12.46%
386,491 $1.36 Million
Q1 2021

Apr 21, 2021
BUY
$6.34 - $12.68 $2.8 Million - $5.6 Million
441,491 New
441,491 $3.02 Million

Others Institutions Holding VYNE

# of Institutions
2
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $171M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Deltec Asset Management LLC Portfolio

Follow Deltec Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deltec Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Deltec Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email